Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NNFA DHEA campaign

This article was originally published in The Tan Sheet

Executive Summary

The National Nutritional Foods Association is planning a "grassroots" campaign to oppose a new bill that would reclassify dehydroepiandrosterone (DHEA) as an anabolic steroid. The proposed legislation would add a "safe and effective" supplement to the list of controlled substances, "effectively banning it," the trade group maintains. Sens. Charles Grassley (R-Iowa), John McCain (R-Ariz.) and George Allen (R-Va.) introduced the bill May 26 (1"The Tan Sheet" June 6, 2005, p. 11)...

You may also be interested in...



DHEA Debate Returns To Fore: Anabolic Steroid Status Sought In Grassley Bill

A new bill sponsored by Sen. Charles Grassley (R-Iowa) would regulate dehydroepiandrosterone (DHEA) as an anabolic steroid under the Controlled Substances Act

Court Rules More Trial Data Must Be Posted On ClinicalTrials.gov

Plaintiff Peter Lurie, former US FDA associate commissioner, expects results of hundreds of clinical trials of approved drugs will become available under ruling against HHS; co-plaintiff sought eteplirsen study data.

Drug Shortages Loom If Coronavirus Persists In China, Generics Execs Say

Drug shortages will become a bigger issue in a few months if ingredient supply disruptions in China persist, Bernstein analyst Gal concluded from discussions with four generic executives. 

Topics

UsernamePublicRestriction

Register

PS098312

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel